N@N

Market Maker Surveillance Report. ANIK, ALXA, SINO, BSPM, BLIN, DGAZ, Losing Stocks With Lowest Price Friction For Wednesday,

December 5, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4194 companies with "abnormal" market making, 2650 companies with positive Friction Factors and 2786 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Wednesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Anika Therapeutics Inc (NASDAQ:ANIK), Alexza Pharmaceuticals Inc (NASDAQ:ALXA), Sino-Global Shipping America Ltd (NASDAQ:SINO), Biostar Pharmaceuticals Inc (NASDAQ:BSPM), Bridgeline Digital Inc (NASDAQ:BLIN), (NYSE:DGAZ). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  ANIK    $-2.530   -21.17%   131,478      34.05%    239,829      62.11%    -108,351     -428    
  ALXA    $-0.640   -11.59%   833,320      47.47%    934,271      53.22%    -100,951     -1,577  
  SINO    $-0.240   -12.70%   53,398       42.78%    71,432       57.22%    -18,034      -751    
  BSPM    $-0.130   -11.02%   35,826       35.05%    66,389       64.95%    -30,563      -2,351  
  BLIN    $-0.400   -17.78%   118,291      37.72%    185,296      59.09%    -67,005      -1,675  
  DGAZ    $-2.200   -12.17%   48,306       31.50%    64,740       42.22%    -16,434      -75     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows ANIK with a dollar loss Wednesday of $-2.53000 and a Friction Factor of -428 shares. That means that it only took 428 more shares of selling than buying to move ANIK lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

Anika Therapeutics Inc (NASDAQ:ANIK) - Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body. The company offers ORTHOVISC, which is used for the treatment of osteoarthritis in knees and various joints; ORTHOVISC mini that is used for the treatment of osteoarthritis in small joints; and MONOVISC, a single injection product used for the treatment of osteoarthritis in various joints. It also provides wound care products that comprise Hyalograft 3D used for the regeneration of skin; and Hyalomatrix used for the treatment of burns and ulcers. In addition, the company offers AMVISC, AMVISC Plus, STAARVISC-II, and ShellGel, which are injectable HA products used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation. Further, it provides INCERT, a HA based product used for the prevention of post-surgical adhesions; Hyalobarrier and Hyalobarrier Endo, which are post operative adhesion barriers for abdominal indications; and HYVISC, an HA product used for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine osteoarthritis. Additionally, the company offers Merogel, a product used for the treatment of ear, nose, and throat disorders. It also provides products for facial wrinkles and scar remediation under the HYDRELLE and ELEVESS brand names. Anika Therapeutics, Inc. sells its products directly, as well as through a network of distributors primarily in the United States, Europe, and Turkey. The company was founded in 1983 and is headquartered in Bedford, Massachusetts..

Alexza Pharmaceuticals Inc (NASDAQ:ALXA) - Alexza Pharmaceuticals, Inc., a development stage company, focuses on the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are based on a proprietary technology, the Staccato system that vaporizes an excipient-free drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery. The companys clinical-stage product candidates comprise AZ-004 (staccato loxapine), which is licensed to Biovail Laboratories International SRL for the acute treatment of agitation in patients with schizophrenia or bipolar disorder; AZ-007 (staccato zaleplon), which completed phase I status for the treatment of insomnia; and AZ-001 (staccato prochlorperazine) and AZ-104 (staccato loxapine, low-dose), phase II product candidates for the treatment of migraine headache. It also develops AZ-002 (Staccato alprazolam), which completed a phase 1 clinical trial in healthy subjects and a phase 2a proof-of-concept clinical trial in panic disorder patients for the treatment of panic attacks; and AZ-003 (Staccato fentanyl) that completed phase 1 clinical trial for the treatment of patients with acute pain, including patients with breakthrough cancer pain and postoperative patients with acute pain episodes. The company was formerly known as Alexza Molecular Delivery Corporation and changed its name to Alexza Pharmaceuticals, Inc. in July 2005. Alexza Pharmaceuticals, Inc. was founded in 2000 and is based in Mountain View, California..

Sino-Global Shipping America Ltd (NASDAQ:SINO) - Sino-Global Shipping America, Ltd., through its subsidiaries, provides shipping agency services primarily in the Peoples Republic of China. The company offers its services for foreign ships coming to Chinese ports. It provides general shipping agency services in 76 ports. The company provides shipping services for bulk and break-bulk general cargo, and vehicle transport, as well as for raw materials, such as crude oil, oil products, iron, manganese, and other metal ores. It also provides various additional services, including preparing documents, husbanding vessels, working through customs issues, coordinating matters with port authorities, overseeing and settling cargo claims, tracking shipments, recommending trucking, warehousing, and complementary services. The company was founded in 2001 and is based in Flushing, New York..

Biostar Pharmaceuticals Inc (NASDAQ:BSPM) - Biostar Pharmaceuticals, Inc., through its subsidiary, Shaanxi Biostar Biotech, Ltd., discovers, develops, manufactures, and markets over-the-counter and prescription pharmaceutical products, and nutrient products for various diseases and conditions in the Peoples Republic of China. Its primary product is Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B. The companys products also include Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat pain, headache, and fever; and Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for the treatment of pain and other symptoms associated with menstruation. Its prescription pharmaceutical products comprise Danshen granule for the treatment of coronary heart disease, myocarditis, and angina pectoris; and Taohuasan pediatric medicine for the treatment of bronchial congestion and coughs in children. In addition, the company holds licenses to produce and sell 13 nutrient products. Biostar Pharmaceuticals sells its products to pharmacies directly, as well as through a network of 20 distributors. It has research and development agreements with Fourth Military Medical University Xijing Hospital State Drug Clinical Research Center to conduct clinical trial for new drugs. The company was founded in 1995 and is headquartered in Xianyang City, the Peoples Republic of China..

Bridgeline Digital Inc (NASDAQ:BLIN) - Bridgeline Digital, Inc. operates as a developer of Web application management software and interactive business technology solutions that help organizations optimize business processes. Its iAPPS Product Suite is a software-as-a-service solution that unifies content management, analytics, e-commerce, and e-marketing capabilities enabling business users to swiftly enhance and optimize the value of their Web properties. The company helps customers to maximize the value of their rapidly changing Web applications with interactive technology services by Microsoft Gold Certified development teams. It specializes in Web application development, usability engineering, SharePoint development, rich media development, and search engine optimization. The company was formerly known as Bridgeline Software, Inc. and changed its name to Bridgeline Digital, Inc. in March 2010. Bridgeline Digital, Inc. was founded in 2000 and is based in Woburn, Massachusetts..

(NYSE:DGAZ) - .

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net